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Recent researches demonstrate a correlation between polyamine intake or intestinal 
exposure, to risk of colorectal neoplasia (Vargas et al., 2012). Furthermore, the role of 
polyamines, spermidine (SPD) and spermine (SPM), and their precursor putrescine (PUT), 
regulated in their cellular levels by ornithine decarboxylase (ODC), in cell growth and 
proliferation is very well recognized. Increased polyamine levels are observed also in 
patients with IBD with their corresponding inflammatory index revealed that increased 
concentrations of polyamines found in the most severe inflamed mucosal areas. Some 
probiotics seem to have anti-inflammatory and tumor inhibitory properties, but few 
studies have investigated their actions on mucosal polyamine levels. Recently, a 
demonstration that dysbiosis is associated with canine inflammatory colorectal polyps 
(ICRPs) development, and that this may represents a potential therapeutic target, was 
published (Igarashi et al, 2016). In this study, the effects of probiotic mixture on colonic 
polyamine biosynthesis in dogs with colonic polyposis (CP) were investigated. Histological 
sections of dogs with a long-time diagnosis of colonic polyposis (n=5) were analyzed. 
These dogs had received between 112 and 225 billion (112 to 225 x 109) of lyophilized 
bacteria daily for 60 days, and samples were obtained at baseline (T0) and 30 days after 
the end of treatment (T1; i.e. 90 days after T0). Histology scores, the expression of PUT, 
SPM, ODC and DAO positive cells, and the clinical activity index (CIBDAI) were compared 
at T0 and T1 using paired t-tests or Wilcoxon matched pairs tests, where appropriate. 
Additionally, levels of cellular proliferation (Ki-67 expression), and apoptosis (Caspase 3 
protein expression) in the polyp were also evaluated. After probiotic treatment, significant 
decreases were observed for CIBDAI (p=0.006) and histology scores (p<0.001). In 
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contrast, SPM, PUT, and ODC expression increased (p<0.01) after probiotic treatment. 
Specifically, a significant decrease in colonic polyamine levels, ODC activity and Ki-67 
was noted at T1 to T0. In contrast, a significant increase in caspase-3 positive cells and 
DAO expression (p=0.005) was also observed. Polyamines levels suggest a potential anti-
proliferative effect of probiotics in hyperplastic mucosa, but also an anti-inflammatory 
effect associated with a reduction of mucosal infiltration. These effects could be related to 
increase in some bacteria genera such Faecalibacterium after probiotic treatment. 
Interestingly Faecalibacterium catalyzes the irreversible transfer of a propylamine group 
from the amino donor S-adenosylmethioninamine (decarboxy-AdoMet) to putrescine (1,4-
diaminobutane) to yield spermidine, increasing PUT and SPD levels (van Vliet MJ, 2010). 
In conclusion, this study provides data about the ability of a cocktail of probiotics, 
administered for 8 weeks, to regulate polyamine levels, by enhancing polyamine 
biosynthesis and degradation in canine inflamed polypoid colonic mucosa, and to reduce 
cell proliferation in hyperplastic/neoplastic areas. 
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